Sort   by:  
 Page size 
Proteomicsurinary glycopeptide profile differentiates early cardiorenal risk in subjects not meeting criteria for chronic kidney disease
Early diagnosis and treatment of chronic kidney disease (CKD) is a worldwide challenge. Albuminuria is defined as urinary albumin:creatinine ratio (ACR) ≥30 mg/g. Subjects with ACR values below this cut-off and preserved renal function are considered at no cardiorenal risk, but increased risk is est...
ORGANISM(S): Homo sapiens (Human) 
2025-06-02 | PXD049688 | Pride
Urine  glycopeptide  chronic kidney disease  early cardiorenal risk albuminuria 
UnknownThe Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease.
Not available
S-EPMC11241500 | biostudies-literature
UnknownTCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension.
Not available
S-EPMC8301016 | biostudies-literature
UnknownCardiorenal metabolic biomarkers link early life stress to risk of non-communicable diseases and adverse mental health outcomes.
Not available
S-EPMC7413400 | biostudies-literature
UnknownRisk factors and early prediction of cardiorenal syndrome type 3 among acute kidney injury patients: a cohort study.
Not available
S-EPMC11086006 | biostudies-literature
UnknownEarly prediction of sepsis-induced cardiorenal syndrome: superiority of myoglobin over troponin I.
Not available
S-EPMC12366516 | biostudies-literature
UnknownNonsteroidal Mineralocorticoid Receptor Antagonist (Finerenone) in Cardiorenal Disease.
Not available
S-EPMC10573495 | biostudies-literature
UnknownCardiorenal Risk Profiles Among Data-Driven Type 2 Diabetes Sub-Phenotypes: A Post-Hoc Analysis of the China Health and Nutrition Survey.
Not available
S-EPMC9019482 | biostudies-literature
UnknownIdentification and predicting short-term prognosis of early cardiorenal syndrome type 1: KDIGO is superior to RIFLE or AKIN.
Not available
S-EPMC4277271 | biostudies-literature
ProteomicsExosome-Based Proteomic Profiling for Biomarker Discovery in Pediatric Fabry Disease: Insights into Early Diagnosis Monitoring
Background: Fabry disease (FD) is an X-linked lysosomal storage disorder caused by GLA mutations, leading to deficient α-galactosidase A (α-Gal A) activity and progressive glycosphingolipid accumulation. While α-Gal A activity is the diagnostic gold standard, its sensitivity is reduced in late-onset...
ORGANISM(S): Homo sapiens (Human) 
2025-12-08 | PXD069403 | Pride
Child Fabry disease Exosome Biomarkers 
Sort   by:  
 Page size